A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer

LESSONS LEARNED. Coadministration of S‐1 and paclitaxel in elderly patients with advanced non‐small cell lung cancer showed favorable efficacy. Coadministration of S‐1 and paclitaxel in elderly patients with advanced non‐small lung cancer showed tolerable toxicity. BACKGROUND. Although monotherapy w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Yoshimura, Akihiro, Chihara, Yusuke, Date, Koji, Tamiya, Nobuyo, Takemura, Yoshizumi, Imabayashi, Tatsuya, Kaneko, Yoshiko, Yamada, Tadaaki, Ueda, Mikio, Arimoto, Taichiro, Uchino, Junji, Iwasaki, Yoshinobu, Takayama, Koichi
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2018
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6459255/
https://ncbi.nlm.nih.gov/pubmed/30578309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0858
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires